Department of Health and Human Services, Centers for Medicare & Medicaid Services: Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2023 Rates; Quality Programs and Medicare Promoting Interoperability Program Requirements for Eligible Hospitals and Critical Access Hospitals; Costs Incurred for Qualified and Non-Qualified Deferred Compensation Plans; and Changes to Hospital and Critical Access Hospital Conditions of Participation
Highlights
GAO reviewed the Department of Health and Human Services, Centers for Medicare & Medicaid Services' (CMS) new rule entitled "Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2023 Rates; Quality Programs and Medicare Promoting Interoperability Program Requirements for Eligible Hospitals and Critical Access Hospitals; Costs Incurred for Qualified and Non-Qualified Deferred Compensation Plans; and Changes to Hospital and Critical Access Hospital Conditions of Participation." GAO found that the final rule will (1) revise the Medicare hospital inpatient prospective payment systems for operating and capital-related costs of acute care hospitals, make changes relating to Medicare graduate medical education for teaching hospitals, and update the payment policies and the annual payment rates for the Medicare prospective payment system (PPS) for inpatient hospital services provided by long-term care hospitals; (2) establish new requirements and revise existing requirements for eligible hospitals and critical access hospitals participating in the Medicare Promoting Interoperability Program, as well as update policies for the Hospital Readmissions Reduction Program, Hospital Inpatient Quality Reporting Program, Hospital Value-Based Purchasing Program, Hospital-Acquired Condition Reduction Program, PPS-Exempt Cancer Hospital Reporting Program, and the Long-Term Care Hospital Quality Reporting Program; (3) revise the hospital and critical access hospital conditions of participation for infection prevention and control and antibiotic stewardship programs, and codify and clarify policies related to the costs incurred for qualified and non-qualified deferred compensation plans; (4) provide updates on the Rural Community Hospital Demonstration Program and the Frontier Community Health Integration Project.
Enclosed is our assessment of CMS's compliance with the procedural steps required by section 801(a)(1)(B)(i) through (iv) of title 5 with respect to the rule. If you have any questions about this report or wish to contact GAO officials responsible for the evaluation work relating to the subject matter of the rule, please contact Shari Brewster, Assistant General Counsel, at (202) 512-6398.
B-334522
August 19, 2022
The Honorable Ron Wyden
Chairman
The Honorable Mike Crapo
Ranking Member
Committee on Finance
United States Senate
The Honorable Frank Pallone, Jr.
Chairman
The Honorable Cathy McMorris Rodgers
Republican Leader
Committee on Energy and Commerce
House of Representatives
The Honorable Richard Neal
Chairman
The Honorable Kevin Brady
Ranking Member
Committee on Ways and Means
House of Representatives
Subject: Department of Health and Human Services, Centers for Medicare & Medicaid Services: Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2023 Rates; Quality Programs and Medicare Promoting Interoperability Program Requirements for Eligible Hospitals and Critical Access Hospitals; Costs Incurred for Qualified and Non-Qualified Deferred Compensation Plans; and Changes to Hospital and Critical Access Hospital Conditions of Participation
Pursuant to section 801(a)(2)(A) of title 5, United States Code, this is our report on a major rule promulgated by the Department of Health and Human Services, Centers for Medicare & Medicaid Services (CMS) entitled “Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2023 Rates; Quality Programs and Medicare Promoting Interoperability Program Requirements for Eligible Hospitals and Critical Access Hospitals; Costs Incurred for Qualified and Non-Qualified Deferred Compensation Plans; and Changes to Hospital and Critical Access Hospital Conditions of Participation” (RIN: 0938‑AU84). We received the rule on August 4, 2022. It was published in the Federal Register as a final rule on August 10, 2022. 87 Fed. Reg. 48780. The effective date is October 1, 2022.
According to CMS, the final rule will revise the Medicare hospital inpatient prospective payment systems for operating and capital-related costs of acute care hospitals, make changes relating to Medicare graduate medical education for teaching hospitals, and update the payment policies and the annual payment rates for the Medicare prospective payment system (PPS) for inpatient hospital services provided by long-term care hospitals. CMS further stated the final rule will establish new requirements and revise existing requirements for eligible hospitals and critical access hospitals participating in the Medicare Promoting Interoperability Program, as well as update policies for the Hospital Readmissions Reduction Program, Hospital Inpatient Quality Reporting Program, Hospital Value-Based Purchasing Program, Hospital-Acquired Condition Reduction Program, PPS-Exempt Cancer Hospital Reporting Program, and the Long-Term Care Hospital Quality Reporting Program. CMS stated it will also revise the hospital and critical access hospital conditions of participation for infection prevention and control and antibiotic stewardship programs, and codify and clarify policies related to the costs incurred for qualified and non-qualified deferred compensation plans. Lastly, according to CMS, the final rule will provide updates on the Rural Community Hospital Demonstration Program and the Frontier Community Health Integration Project.
The Congressional Review Act (CRA) requires a 60-day delay in the effective date of a major rule from the date of publication in the Federal Register or receipt of the rule by Congress, whichever is later. 5 U.S.C. § 801(a)(3)(A). The final rule was published on August 10, 2022. 87 Fed. Reg. 48780. The effective date is October 1, 2022. Therefore, the final rule does not have the required 60-day delay in its effective date.
Enclosed is our assessment of CMS’s compliance with the procedural steps required by section 801(a)(1)(B)(i) through (iv) of title 5 with respect to the rule. If you have any questions about this report or wish to contact GAO officials responsible for the evaluation work relating to the subject matter of the rule, please contact Shari Brewster, Assistant General Counsel, at (202) 512-6398.
Shirley A. Jones
Managing Associate General Counsel
Enclosure
cc: Calvin E. Dukes II
Regulations Coordinator
Department of Health and Human Services
ENCLOSURE
REPORT UNDER 5 U.S.C. § 801(a)(2)(A) ON A MAJOR RULE
ISSUED BY THE
DEPARTMENT OF HEALTH AND HUMAN SERVICES,
CENTERS FOR MEDICARE & MEDICAID SERVICES
ENTITLED
“MEDICARE PROGRAM; HOSPITAL INPATIENT PROSPECTIVE PAYMENT SYSTEMS
FOR ACUTE CARE HOSPITALS AND THE LONG-TERM CARE
HOSPITAL PROSPECTIVE PAYMENT SYSTEM AND POLICY CHANGES
AND FISCAL YEAR 2023 RATES; QUALITY PROGRAMS AND MEDICARE PROMOTING
INTEROPERABILITY PROGRAM REQUIREMENTS FOR ELIGIBLE HOSPITALS
AND CRITICAL ACCESS HOSPITALS; COSTS INCURRED FOR QUALIFIED
AND NON-QUALIFIED DEFERRED COMPENSATION PLANS; AND CHANGES TO
HOSPITAL AND CRITICAL ACCESS HOSPITAL CONDITIONS OF PARTICIPATION”
(RIN: 0938-AU84)
(i) Cost-benefit analysis
The Department of Health and Human Services, Centers for Medicare & Medicaid Services (CMS) estimated the final rule would lead to an increase in payments from the federal government to inpatient prospective payment system Medicare providers in the amount of $1.4 billion. CMS further estimated the final rule would increase payments from the federal government to long-term care hospital Medicare providers in the amount of $71 million. CMS summarized the costs, benefits, and transfers associated with specific provisions.
(ii) Agency actions relevant to the Regulatory Flexibility Act (RFA), 5 U.S.C. §§ 603–605, 607, and 609
CMS stated the final rule would have a significant economic impact on a substantial number of small entities and included the analysis in the final rule. CMS also described the impact the final rule would have on small rural hospitals.
(iii) Agency actions relevant to sections 202–205 of the Unfunded Mandates Reform Act of 1995, 2 U.S.C. §§ 1532–1535
CMS stated the final rule would not mandate any requirements that meet the threshold for state, local, or tribal governments, nor would it affect private sector costs.
(iv) Other relevant information or requirements under acts and executive orders
Administrative Procedure Act, 5 U.S.C. §§ 551 et seq.
On May 10, 2022, CMS published a proposed rule. 87 Fed. Reg. 28108. CMS received comments and addressed them in the final rule.
Paperwork Reduction Act (PRA), 44 U.S.C. §§ 3501–3520
CMS determined the final rule contained information collection requirements (ICRs) subject to the Act. The ICRs address areas such as the hospital wage index, payment for low-volume hospitals, the Hospital Inpatient Quality Reporting Program, the PPS-Exempt Cancer Hospital Quality Reporting Program, the Hospital Value-Based Purchasing Program, the Hospital-Acquired Condition Reduction Program, the Hospital Readmissions Reduction Program, the Medicare Promoting Interoperability Program, the Long-Term Care Hospital Quality Reporting Program, costs incurred for qualified and non-qualified deferred compensation plans, and conditions of participation requirements for hospitals and critical access hospitals to continue reporting data for COVID-19 and influenza after the public health emergency ends as determined by the Secretary. CMS estimated the burdens for ICRs in the final rule.
Statutory authorization for the rule
CMS promulgated the final rule pursuant to sections 1302, 1395, 1395d, 1395f, 1395g, 1395l, 1395x, 1395hh, 1395rr, 1395tt, and 1395ww of title 42, United States Code.
Executive Order No. 12866 (Regulatory Planning and Review)
CMS stated the final rule has been reviewed by OMB.
Executive Order No. 13132 (Federalism)
CMS determined the final rule would not have a substantial direct effect on state or local governments, preempt states, or otherwise have a federalism implication.